NDC 73606-010

Empaveli 1080 mg per 20 mL injection, solution

On the label: Apellis Pharmaceuticals, Inc..

Switzerland: 1United States: 1France: 1Japan: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Bachem AGBubendorf, SwitzerlandMakes the active ingredient Problems found, fixed voluntarilyAug 16, 2024 · 4 inspections
Bora Pharmaceuticals Injectables Inc.Baltimore, MD, United StatesMakes it Problems found, fixed voluntarilyAug 10, 2023 · 12 inspections, 1 with FDA action
Cenexi HSCHerouville-Saint-Clair, FranceMakes it, tests it, packages it and sterilizes it Problems found, fixed voluntarilyMar 1, 2024 · 2 inspections
Juzen Chemical CorporationToyama-city, JapanMakes the active ingredient Problems found, fixed voluntarilyAug 1, 2025 · 6 inspections
AndersonBrecon Inc.Rockford, IL, United StatesPackages it No problems foundAug 19, 2026 · 11 inspections
Eurofins Advantar Laboratories, LLCSan Diego, CA, United StatesTests it Problems found, fixed voluntarilyJun 30, 2026 · 3 inspections
Eurofins Lancaster Laboratories, LLCLancaster, PA, United StatesTests it Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections
Nelson Laboratories, LLCSalt Lake City, UT, United StatesTests it Problems found, fixed voluntarilyJun 2, 2023 · 6 inspections

Product details

Generic drug
Pegcetacoplan: every company that makes it
Form
injection, solution, subcutaneous
Strength
1080 mg per 20 mL
Approval
NDA NDA215014
On the market since
May 14, 2021
Package NDCs
73606-010-01
Official label
DailyMed (National Library of Medicine), updated Aug 21, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?